I think the poster will contain details of this study.
"Further studies in a mouse model, in which human ovarian cancer cell line OV90 was examined, showed both intraperitoneal and oral Kevetrin administration were successful in prolonging survival."
http://www.cellceutix.com/press-release/2016/...e33i3z6z29
"Further studies in a mouse model, in which human ovarian cancer cell line OV90 was examined, showed both intraperitoneal and oral Kevetrin administration were successful in prolonging survival."
http://www.cellceutix.com/press-release/2016/...e33i3z6z29
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links